(Q34167930)

31 July 2017

1 reference

title

In vivo tracking of tumor-specific T cells (English)

1 reference

31 July 2017

Yee C

1

1 reference

PubMed ID

11228405

31 July 2017

Riddell SR

series ordinal

2

1 reference

PubMed ID

11228405

31 July 2017

Greenberg PD

series ordinal

3

1 reference

31 July 2017

1 April 2001

1 reference

Current Opinion in Immunology

31 July 2017

1 reference

31 July 2017

13

1 reference

31 July 2017

141-146

1 reference

31 July 2017

2

1 reference

T cell defined tumor antigens

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

Limiting dilution assays for the determination of immunocompetent cell frequencies. III. Validity tests for the single-hit Poisson model.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

Detection and quantification of blood-derived CD8+ T lymphocytes secreting tumor necrosis factor alpha in response to HLA-A2.1-binding melanoma and viral peptide antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

The use of computer-assisted video image analysis for the quantification of CD8+ T lymphocytes producing tumor necrosis factor alpha spots in response to peptide antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

Flow cytometric measurement of intracellular cytokines.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

HIV-specific cytotoxic T lymphocytes traffic to lymph nodes and localize at sites of HIV replication and cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

In vivo migration and function of transferred HIV-1-specific cytotoxic T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

Expression of herpes simplex virus ICP47 and human cytomegalovirus US11 prevents recognition of transgene products by CD8(+) cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

Phenotypic analysis of antigen-specific T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

Direct visualization of antigen-specific T cells: HTLV-1 Tax11-19- specific CD8(+) T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM/TSP patients

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

Detection of antigen-specific T cells with multivalent soluble class II MHC covalent peptide complexes.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

CD8(+) T-cell selection, function, and death in the primary immune response in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

In situ detection of virus- and tumor-specific T-cell immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

Putative immunodominant human immunodeficiency virus-specific CD8(+) T-cell responses cannot be predicted by major histocompatibility complex class I haplotype

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

Massive expansion of antigen-specific CD8+ T cells during an acute virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus In vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

Direct isolation, phenotyping and cloning of low-frequency antigen-specific cytotoxic T lymphocytes from peripheral blood.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

A new look at T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

Viral immune evasion due to persistence of activated T cells without effector function

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

Antigen-independent activation of naive and memory resting T cells by a cytokine combination

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

Induction of antigen-specific cytolytic T cells in situ in human melanoma by immunization with synthetic peptide-pulsed autologous antigen presenting cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of t cell-mediated vitiligo.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

Clonal expansion of Melan A-specific cytotoxic T lymphocytes in a melanoma patient responding to continued immunization with melanoma-associated peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

Status of activation of circulating vaccine-elicited CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

Enhanced antigen-specific antitumor immunity with altered peptide ligands that stabilize the MHC-peptide-TCR complex

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

The central role of CD4(+) T cells in the antitumor immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

MHC class II tetramers identify peptide-specific human CD4(+) T cells proliferating in response to influenza A antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900196-5

7 January 2021

10.1016/S0952-7915(00)00196-5

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

11228405